Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 237 Show results per page	View Search Criteria \| Help With Results

Last Modified: 11/13/2008 First Published: 8/1/1998


1.		Phase II Study of Observation in Patients With Favorable Low-Grade Glioma and a Phase III Study of Radiotherapy With or Without Procarbazine, Lomustine, and Vincristine in Patients With Unfavorable Low-Grade Glioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 and over				NCI				RTOG-9802 E-R9802, NCCTG-R9802, SWOG-R9802, RTOG-DEV-1012, NCT00003375, RTOG-98-02


2.		Phase II-III Chemotherapy with ADR/VCR/ARA-C plus Immunotherapy with BCG and Irradiated Cells for Acute Myelogenous Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				under 60								EORTC-LAM-4

Last Modified: 2/1/1993


3.		Phase II/III Study of Chemotherapy with VP-16/CACP plus Radiotherapy Followed by Chemotherapy with the Drug or Drug Combination Selected on the Basis of In-Vitro Drug Sensitivity Tests in Patients with Limited Stage Small Cell Carcinoma of the Lung (Summary Last Modified 02/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 and over				NCI				NCI-86-C-92A NCI-NMOB-855, NCI-T86-0137N, T86-0137

Last Modified: 9/1/1994


4.		Phase III Randomized Study of Intensive PCV (PCB/CCNU/VCR) Given Prior to Radiotherapy vs Upon Recurrence in Adults with Supratentorial Anaplastic Astrocytoma (Summary Last Modified 09/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				over 16								EORTC-26921

Last Modified: 9/1/1994


5.		Phase III Randomized, Placebo-Controlled Study of CCNU with vs without Benznidazole in Patients with Malignant Glioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 75								MRC-BR03 EU-94010

Last Modified: 7/20/2007


6.		Phase III Randomized Study of Radiotherapy with vs without BUDR and Followed by PCV (PCB/CCNU/VCR) for Anaplastic Astrocytomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				RTOG-9404 NCCTG-947251, SWOG-9340, RTOG-94-04

Last Modified: 4/4/2008 First Published: 7/1/1994


7.		Phase III Randomized Study of Radiotherapy With or Without Intensive Procarbazine, Lomustine, and Vincristine (PCV) in Patients With Unifocal or Multifocal, Supratentorial, Pure or Mixed Anaplastic Oligodendroglioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				RTOG-9402 CAN-NCIC-CE2, E-R9402, NCCTG-927252, SWOG-9402, INT-0149, NCT00002569, CE2

Last Modified: 10/1/1994


8.		Phase III Randomized Study of Radiotherapy with vs without CTX/MTX/CCNU for Limited Stage and of CTX vs CTX/MTX/CCNU for Extensive Stage Small Cell Lung Cancer (Summary Last Modified 10/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				70 and under								MRC-LU03 EU-94018

Last Modified: 10/1/1994


9.		Phase III Randomized Study of Sequential vs Alternating Radiotherapy and CTX/MTX/CCNU for Limited Stage Small Cell Lung Cancer (Summary Last Modified 10/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				70 and under								MRC-LU04 EU-94019

Last Modified: 4/26/2007


10.		Phase III Chemohormonal Therapy with ADR/CCNU/VCR/FXM vs CTX/MPA plus Immunotherapy with C. parvum for Metastatic Renal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				20 to 70								MSHMC-REN-2

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute